Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Hydrogenation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel catalytic route for Tofacitinib reduces steps and improves purity. Ideal for pharmaceutical intermediate manufacturing cost reduction and supply chain reliability.
Patent CN101142164B details a cost-effective route to Synthon A using planar chiral diphosphine catalysts, offering high ee and scalability for API manufacturing.
Patent CN1759097A details a safer process for PDF inhibitor intermediates using specific beta-lactams and selective debenzylation, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN114085219B details asymmetric hydrogenation for high-purity pharmaceutical intermediates. Offers cost reduction and scalable supply chain solutions for global buyers.
Patent CN114605272A details a novel Nickel-catalyzed asymmetric hydrogenation route for (R)-Fluoxetine intermediates, offering significant cost reduction and high enantioselectivity for API manufacturing.
Novel chiral auxiliary method for rasagiline production offering high yield and reduced pollution for pharmaceutical manufacturers seeking reliable supply chains.
Patent CN112142784B details iridium-catalyzed asymmetric hydrogenation yielding high-purity chiral amines with >99% ee, enabling cost-effective API manufacturing.
Patent CN113979983A reveals a high-efficiency Rh-catalyzed hydrogenation route for Fidarestat intermediates, offering superior enantioselectivity and cost reduction for pharmaceutical manufacturing.
Patent CN108046995A reveals a novel one-pot asymmetric synthesis route for chiral intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN108046995A reveals a novel one-pot asymmetric synthesis for chiral intermediates. Discover cost-effective manufacturing and high-purity supply chain solutions.
Novel Ir-catalyzed process for S-indoline-2-carboxylic acid offers high purity and yield. Ideal for reliable pharmaceutical intermediates supplier partnerships.
Patent CN103755743B details a stable method for producing ruthenium carboxylate complexes, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN113603691A details a high-yield Rh-catalyzed process for L-5-methyltetrahydrofolic acid calcium, offering superior purity and cost efficiency for global supply chains.
Patent CN112961194A discloses novel tridentate PNO ligands enabling high ee and yield in ketone hydrogenation, offering robust supply chain solutions for pharma intermediates.
Advanced Ir-catalyzed asymmetric hydrogenation for beta-amino acid esters. Delivers 99% ee and 95% yield. Reliable pharmaceutical intermediates supplier for scalable production.
Patent CN113354554B details an efficient Iridium-catalyzed asymmetric hydrogenation route for carbapenem intermediates, offering superior stereoselectivity and scalable manufacturing capabilities.
Patent CN104854071B details asymmetric hydrogenation for high-purity tocopherol precursors. Enhance supply chain reliability and reduce manufacturing costs significantly.
Patent CN1972898A details a novel Rh-catalyzed asymmetric hydrogenation process for unprotected beta-amino acids, offering significant cost reduction and streamlined API manufacturing.
Patent CN1440374A details a high-yield route for renin inhibitors. Offers scalable chiral synthesis for pharma intermediates with superior purity.
Patent CN107021884A reveals high-efficiency Ir/f-amphox catalysis for chiral 1,2-amino alcohols, offering superior TON and enantioselectivity for pharmaceutical manufacturing.